Filing Details
- Accession Number:
- 0001209191-20-058492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-16 17:12:40
- Reporting Period:
- 2020-11-16
- Accepted Time:
- 2020-11-16 17:12:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586892 | D Daniel Shoemaker | C/O Fate Therapeutics, Inc.; 3535 General Atomics Court #200 San Diego CA 92121 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-16 | 4,932 | $50.37 | 113,159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-16 | 5,287 | $51.60 | 107,872 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-16 | 14,781 | $52.40 | 93,091 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020.
- Represents the weighted average sale price of the shares sold ranging from $49.91 to $50.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $50.95 to $51.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $51.96 to $52.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
